← SynDRA
INCB-057643
SynDRA canonical compound SYN0040039 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | BRD2 | BRD3 | BRD4 |
| Mechanism of action | bromodomain inhibitor |
All known targets
Mechanisms of action (all sources)
- BET bromodomain inhibitor
Drug classes
Cross-references
Synonyms
- INCB057643
- INCB 057643
- UNII-87TZD0JEBS
- 87TZD0JEBS
- 2,2,4-trimethyl-8-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-6-(methylsulfonyl)-2H-benzo[b][1,4]oxazin-3(4H)-one
- 2,2,4-Trimethyl-8-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo(2,3-C)pyridin-4-yl)-6-(methylsulfonyl)-2H-benzo(b)(1,4)oxazin-3(4H)-one
- CHEMBL4594412
- SCHEMBL17200525
- US9957268, Example 75
- BDBM391587
- BCP29506
- EX-A1908
- NSC807398
- s8714
- NSC-807398
- BS-16298
- HY-111485
- AK00799038
- CS-0042192
- CC1(OC2=C(N(C1=O)C)C=C(C=C2C=2C1=C(C(N(C2)C)=O)NC=C1)S(=O)(=O)C)C
- 2,2,4-trimethyl-8-(6-methyl-7- oxo-6,7-dihydro-1H- pyrrolo[2,3-c]pyridin-4-yl)-6- (methylsulfonyl)-2H-1,4- benzoxazin-3(4H)-one
- 2H-1,4-Benzoxazin-3(4H)-one, 8-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo(2,3-C)pyridin-4-yl)-2,2,4-trimethyl-6-(methylsulfonyl)-
- RefChem:148083
- BET Inhibitor INCB057643
- orb1301806
- SCHEMBL29422923
- INCB057643?
- INCB-057643?
- AKOS037515683
- AC-35555
- BI166425
- DA-64432
- PD132573
- SY389280
- T5417
- D80635
Look up INCB-057643 in the interactive SynDRA portal →